Application
Antibody tested is p-ERα (Ser 118): (A,B,C) and ERα (H226): (D,E,F).Application
Antibodies tested include p-ERα (Ser 118): (A,B,C) and ERα (C-311): (D,E,F).Application
Western blot analysis of ERα phosphorylation in untreated (A) and lambda protein phosphatase treated (B) MCF7 whole cell lysates.Application
Western blot analysis of ERα phosphorylation in untreated (A), β estradiol treated (B) and β estradiol treated and lambda protein phosphatase treated (C) MCF7 whole cell lysates.Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing nuclear localization.Application
Blots were probed with p-ERα (Ser 118): preincubated with cognate phosphorylated peptide (A) and p-ERα (Ser 118): (B).| Product Name | p-ERα Antibody (Ser 118) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | epitope corresponding to phosphorylated Ser 118 of ERα of human origin |
| Modification | Phosphoralated |
| Modification Notes | Estrogen receptor alpha (ERa, ER, ESR, ESRA, Era, NR3A1, estrogen receptor 1) is a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding and activation of transcription. Alternative splicing results in several ERa mRNA transcripts, which differ primarily in their 5' untranslated regions. ERa undergoes phosphorylation in response to estradiol binding. Human ERa is predominately phosphorylated on Ser 118 and to a lesser extent on Ser 104 and Ser 106. In response to activation of the mitogen-activated protein kinase pathway, phosphorylation occurs on Ser 118 and Ser 167. These serine residues are all located within the activation function 1 region of the N-terminal domain of ERa. In contrast, activation of protein kinase A increases the phosphorylation of Ser 236, which is located in the DNA-binding domain. Src kinase-dependent Tyr 537 phosphorylation may enhance estrogen binding to ERa. Mutation of Tyr 537 of the human ERa produces receptors having a range of constitutive activity. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIPIFIHC |
| recommended for detection of Ser 118 phosphorylated ERα of human origin and correspondingly phosphorylated Ser 122 of mouse origin by WB, IP, IF and IHC(P): |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Alternative Names | epitope corresponding to phosphorylated Ser 118 of ER&alpha of human origin |
|---|---|
| Tissue Specificity | epitope corresponding to phosphorylated Ser 118 of ERα of human origin |
| Entrez Gene | 2099 |
|---|
Application
Antibody tested is p-ERα (Ser 118): (A,B,C) and ERα (H226): (D,E,F).
Application
Antibodies tested include p-ERα (Ser 118): (A,B,C) and ERα (C-311): (D,E,F).
Application
Western blot analysis of ERα phosphorylation in untreated (A) and lambda protein phosphatase treated (B) MCF7 whole cell lysates.
Application
Western blot analysis of ERα phosphorylation in untreated (A), β estradiol treated (B) and β estradiol treated and lambda protein phosphatase treated (C) MCF7 whole cell lysates.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing nuclear localization.
Application
Blots were probed with p-ERα (Ser 118): preincubated with cognate phosphorylated peptide (A) and p-ERα (Ser 118): (B).| Application Notes | recommended for detection of Ser 118 phosphorylated ERα of human origin and correspondingly phosphorylated Ser 122 of mouse origin by WB, IP, IF and IHC(P): |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
